|
Outcomes of Education and Counseling for BRCA1 Testing Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Outcomes of Education and Counseling for BRCA1 Testing conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Outcomes of Education and Counseling for BRCA1 Testing Clinical research trials and Outcomes of Education and Counseling for BRCA1 Testing healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Outcomes of Education and Counseling for BRCA1 Testing. Outcomes of Education and Counseling for BRCA1 Testing Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Outcomes of Education and Counseling for BRCA1 Testing clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Outcomes of Education and Counseling for BRCA1 Testing condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "O" Clinical Trials Conditions > Outcomes of Education and Counseling for BRCA1 Testing  Outcomes of Education and Counseling for BRCA1 Testing
Outcomes of Education and Counseling for BRCA1 Testing
For Condition: Breast Neoplasms,Ovarian Neoplasms
Status: Completed
Sponsor(s): National Human Genome Research Institute (NHGRI) ,
Synopsis: This study will identify how personal beliefs, values and family experiences affect a person's decision as to whether or not to be tested for changes in a gene called BRCA1 or BRCA2. Changes in these genes are associated with a significantly increased risk of breast and ovarian cancer in women, a slightly higher risk of prostate cancer in men, and a slightly higher risk of colon cancer in both men and women. Families enrolled in the National Cancer Institute's familial cancer research project who also participated in a telephone survey (protocol 78-C-0039) regarding their level of interest in BRCA1/2 testing results may be eligible for this study. All participants will complete a 20- to 30-minute questionnaire assessing knowledge, risk perception and personality traits, and will participate in an education session to review the following: * Information about their individual cancer risk, based on family history * Potential benefits and risks (medical, psychological and social) of BRCA1/2 testing, both for those who test positive and those who test negative * Overview of DNA testing (what is done and how accurate it may or may not be) * Medical management options for those at increased risk for breast and ovarian cancer * Environmental cancer risk factors * Instruction in breast self-examination Participants will then be asked whether or not they want to undergo BRCA1/2 testing Those who want to be tested will be divided into two groups to compare counseling methods (client-centered vs. counselor-driven counseling). A small blood sample (2 to 3 tablespoons) will be drawn for genetic analysis. Test results will be provided in person at a second visit-this may take 6 months or more. A follow-up telephone call 2 weeks after receipt of the test results will address participants' questions and provide support. During a third visit, scheduled 6 months after receipt of the test results, participants will complete questionnaires evaluating mood, attitude, self-esteem, family interactions, cancer screening practices, and other factors. Finally, 1 year after receipt of the test results, participants will be contacted by telephone and asked about their feelings about the test and its outcome. Individuals who choose not to have gene testing will not participate in any in-person sessions after the initial visit. They will be followed with no more than two telephone interviews to assess their feelings and attitudes related to their decision not to be tested. Individuals may reconsider and change their mind at any time regarding their decision-whether to be tested or not. The results of the study will help experts devise the most effective methods of educating and counseling people at high risk for having an altered BRCA1/2 gene.
Details: Women at increased risk for developing breast and/or ovarian cancer and their first degree relatives will be offered BRCA1/2 gene testing. This study proposes to evaluate psychological and behavioral aspects of their decision-making and the outcomes of the testing process. Knowledge and expectations will be assessed initially, followed by pre-test psychological assessment and an in person education and counseling session. Participants will be presented the choice of whether or not to undergo BRCA1/2 testing. Notification of test results will occur in person along with discussion of available surveillance options. Telephone interviews will assess psychological and behavioral outcome measures at 6 and/or twelve month time points. Aspects of this research endeavor have been designed to complement an NHGRI/NCI extramural consortium and an NHGRI/NCI intramural collaboration both of which will address various aspects of risk notification and follow-up for hereditary breast, ovarian and colon cancer.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Participants will be drawn from the families enrolled by Drs. Peggy Tucker and Jeff Struewing in the GEB of NCI (protocol 78-C-0039). Individual with a family history of verified breast and/or ovarian cancer that includes; a) two cases of ovarian cancer in first degree relatives, or b) three cases of breast cancer and at least one case of ovarian cancer (two of which have to be first degree relatives), or c) at least four cases of breast cancer.
Total Enrollment: 1500
Location and Contact Information:
National Human Genome Research Institute (NHGRI)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 950085; 95-HG-0085
Study Start Date: March 15, 1995
Record last reviewed: February 4, 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001468
Other Breast Neoplasms Studies:
1. Outcomes of Education and Counseling for BRCA1 Testing
2. Tariquidar and Docetaxel to Treat Patients with Lung, Ovarian, and Cervical Cancer
3. A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients
4. Removal of the ovaries/fallopian tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
5. Pilot Study of ZD1839 (Iressa, Gefitinib) in Patients with Advanced Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, or Cervical Cancer
Related Studies:
Other Breast Neoplasms Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Outcomes of Education and Counseling for BRCA1 Testing
|
|
|
|
|
|
|
|
